Appraisal of the evidence linking hereditary α-tryptasemia with mast cell disorders, hypermobility and dysautonomia
- 1 January 2025
- journal article
- research article
- Published by Oceanside Publications Inc. in Allergy and Asthma Proceedings
- Vol. 46 (1) , 4-10
Abstract
Since its first description more than a decade ago, our understanding of the clinical impact of hereditary alpha-tryptasemia has continued to evolve. First considered to be a genetic disorder with a subset of patients having a syndromic presentation composed of connective tissue abnormalities, symptoms of autonomic dysfunction, and findings of mast cell activation, we now know that hereditary alpha-tryptasemia is a common genetic trait and modifier of mast cell‐mediated reactions. More recent studies have shown some previously held associations with congenital hypermobility and postural orthostatic tachycardia syndrome (POTS) to be lacking, and illuminated previously unappreciated associations with clonal and nonclonal mast cell disorders. With the discovery of heterotetrameric tryptases and demonstration of their unique functional activities, the importance of tryptase gene composition in general has begun to take focus. Hereditary alpha-tryptasemia exists at the end of a spectrum of alpha-tryptase expression and as a natural overexpression model of this protein, brought to the fore the potential of tryptase genotyping as a genetic biomarker for anaphylaxis severity. These data and future studies hold the promise of enhancing our understanding of the role that tryptases play in health and disease.Keywords
This publication has 32 references indexed in Scilit:
- Alpha-Tryptase as a Risk-Modifying Factor for Mast Cell–Mediated ReactionsCurrent Allergy and Asthma Reports, 2024
- Differential mast cell mediators in systemic mastocytosis and hereditary α-tryptasemiaJournal of Allergy and Clinical Immunology, 2022
- Mast cell disorders are associated with decreased cerebral blood flow and small fiber neuropathyAnnals of Allergy, Asthma & Immunology, 2022
- Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxisJournal of Allergy and Clinical Immunology, 2022
- On the complexities of tryptase genetics and impact on clinical phenotypesJournal of Allergy and Clinical Immunology, 2021
- Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels aloneJournal of Allergy and Clinical Immunology, 2021
- Inherited and acquired determinants of serum tryptase levels in humansAnnals of Allergy, Asthma & Immunology, 2021
- Heritable risk for severe anaphylaxis associated with increased α-tryptase–encoding germline copy number at TPSAB1Journal of Allergy and Clinical Immunology, 2021
- Clinical Approach to a Patient with Elevated Serum Tryptase: Implications of Acute Versus Basally Elevated Levels2019
- Hereditary Alpha TryptasemiaImmunology and Allergy Clinics of North America, 2018